Abstract
Summary
The purpose of this study was to examine the medical costs and the management of osteoporosis in the 12 months after a closed fracture for men aged ≥ 45 years. The mean medical cost per fracture was high ($6,078–$30,900), and osteoporosis management post fracture was inadequate in the majority of men.
Introduction
This study was conducted in order to examine the medical costs following fracture in males and the management of osteoporosis post fracture.
Methods
Administrative claims from a large, national health plan were analyzed. Men ≥ 45 years were included if they had ≥ 1 medical claim for a new closed fracture between January 1, 2005 and December 31, 2008. Commercially insured (COM) and Medicare Advantage Plan (MAP) members were analyzed separately. Costs were calculated as paid amounts and adjusted to 2010 dollars. Both the differences between the individual patients’ 12-month pre-fracture and 12-month post-fracture costs and the costs directly attributed to the fracture were reported. The prevalence of dual-energy X-ray absorptiometry (DXA) scan and/or osteoporosis pharmacotherapy treatment was evaluated in the 12 months post fracture.
Results
We identified 18,917 (COM, 16,191; MAP, 2,726) men with new closed fractures. Non-hip, non-vertebral fractures (NHNV) were the most common fracture in both COM and MAP populations. Fracture costs ranged from $7,121 to $15,830 for vertebral fractures, from $22,601 to $30,900 for hip fractures, and from $6,078 to $8,344 for NHNV fractures. In the COM and MAP populations, respectively, 8.5 and 15.5 % had a DXA scan and/or osteoporosis pharmacotherapy in the 12 months following the fracture.
Conclusions
Healthcare costs associated with fractures in men are substantial. About 1 in 12 men ≥ 45 years in the COM population were provided adequate follow-up for osteoporosis post fracture. While this rate improved to about one in six men in the MAP population, osteoporosis management in men post fracture is far from optimal.
Similar content being viewed by others
References
National Osteoporosis Foundation. (2011) http://www.nof.org/professionals. Accessed 10 Nov 2011
Nguyen ND, Eisman JA, Center JR, Nguyen TV (2007) Risk factors for fracture in nonosteoporotic men and women. J Clin Endocrinol Metab 92(3):955–962
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475
King AB, Tosteson AN, Wong JB, Solomon DH, Burge RT, Dawson-Hughes B (2009) Interstate variation in the burden of fragility fractures. J Bone Miner Res 24(4):681–692
Bass E, French DD, Bradham DD (2008) A national perspective of Medicare expenditures for elderly veterans with hip fractures. J Am Med Dir Assoc 9(2):114–119
Fransen M, Woodward M, Norton R, Robinson E, Butler M, Campbell AJ (2002) Excess mortality or institutionalization after hip fracture: men are at greater risk than women. J Am Geriatr Soc 50(4):685–690
Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390
Szulc P, Kaufman JM, Orwoll ES (2012) Osteoporosis in men. J Osteoporos 2012:675984
Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162(19):2217–2222
Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, Solomon DH (2004) Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med 19(7):783–790
Follin SL, Black JN, McDermott MT (2003) Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 23(2):190–198
Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS, Avorn J (2005) Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 80(2):194–202
Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35(2):319–326
Diamond T, Sambrook P, Williamson M, Flicker L, Nowson C, Fiatarone-Singh M, Lord S, Ferris L, O'Neil S, MacLennan A (2001) Guidelines for treatment of osteoporosis in men. Aust Fam Physician 30(8):787–791
45 CFR §164.502 (2002) Uses and disclosures of protected health information: general rules. http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=b97f275fe4486f7fd45e455ddcef8296&rgn=div8&view=text&node=45:1.0.1.3.75.5.27.3&idno=45. Accessed 16 May 2012
ICD-9-CM (2012) http://icd9cm.chrisendres.com/index.php?action=child&recordid=8438. Accessed 16 May 2012
Christensen L, Iqbal S, Macarios D, Badamgarav E, Harley C (2010) Cost of fractures commonly associated with osteoporosis in a managed-care population. J Med Econ 13(2):302–313
Huybrechts KF, Ishak KJ, Caro JJ (2006) Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 38(6):922–928
Weycker D, Macarios D, Edelsberg J, Oster G (2007) Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int 18(3):271–277
Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17(11):1645–1652
Kilgore ML, Morrisey MA, Becker DJ, Gary LC, Curtis JR, Saag KG, Yun H, Matthews R, Smith W, Taylor A et al (2009) Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999–2005. J Bone Miner Res 24(12):2050–2055
Kilgore M, Becker D, Curtis J, Saag K, Delzell E, Arora T, Morrisey M (2011) Decomposing health care expenditures relative to fractures. J Bone Miner Res 26(Suppl 1). http://www.asbmr.org/Meetings/AnnualMeeting/Abstract2011.aspx. Accessed 16 May 2012
Frytak JR, Henk HJ, Zhao Y, Bowman L, Flynn JA, Nelson M (2008) Health service utilization among Alzheimer's disease patients: evidence from managed care. Alzheimers Dement 4(5):361–367
US Department of Labor BoLS. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999–2008, Medical Care. http://data.bls.gov/cgi-bin/surveymost?su. 2008. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics. Accessed 26 Oct 2011
Binkley N (2009) A perspective on male osteoporosis. Best Pract Res Clin Rheumatol 23(6):755–768
Ohsfeldt RL, Borisov NN, Sheer RL (2006) Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting. Osteoporos Int 17(2):252–258
Department of Veterans Affairs OoIG. (2010) Management of osteoporosis in veterans with fractures. http://www.va.gov/oig/publications/reports-list.asp. Accessed 26 Oct 2011
Acknowledgments
This study was funded by Amgen Inc. The authors wish to thank Laura Christensen, MS for contributions to the study design, and Gretchen E. Parker, PhD, RAC (OptumInsight) and Yeshi Mikyas, PhD (Amgen Inc.) for assistance with the preparation of this manuscript.
Conflicts of interest
This study was funded by Amgen Inc. NY is an employee of and owns stock or stock options in Amgen Inc. SKB and YF are employees of OptumInsight, which received funding to conduct the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brenneman, S.K., Yurgin, N. & Fan, Y. Cost and management of males with closed fractures. Osteoporos Int 24, 825–833 (2013). https://doi.org/10.1007/s00198-012-2067-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-012-2067-x